An involvement of St 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres®] in cholinergic mechanisms
Authors:
- R.D. RobsonRRR.D. Robson
- H.R. KaplanHKH.R. Kaplan
- 31 March 1969
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 5 (4) , 328-337
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Mechanism of Hypotensive Action of 2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride (ST-155) in the CatJournal of Pharmaceutical Sciences, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968
- Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (catapresan, ST-155)European Journal of Pharmacology, 1968
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967
- ber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit ImidazolinstrukturNaunyn-Schmiedeberg's Archives of Pharmacology, 1967